GlassScriptPhysician profile
Michelle B Uaje
NPI 1659427649
$849.58
in general payments reported to CMS, 2019-2025
19 companies · $37.54 in 2025
The $37.54 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.80 · 2020: $48.01 · 2021: $137 · 2022: $209 · 2023: $154 · 2024: $214 · 2025: $37.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $133.35 | 2019-2022 | |
| Exeltis, USA INC. | $113.27 | 2021-2024 | Slynd |
| Agile Therapeutics, INC. | $103.10 | 2022-2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $68.77 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $60.30 | 2021-2023 | |
| Organon LLC | $58.84 | 2021-2025 | |
| Becton, Dickinson and Company | $48.46 | 2022-2024 | Bd Onclarity |
| Astellas Pharma US INC | $35.35 | 2023-2024 | Veozah |
| Coopersurgical, INC. | $32.39 | 2019-2022 | |
| Sage Therapeutics, LLC | $30.70 | 2024 | |
| Scynexis, INC. | $26.37 | 2022 | |
| Meditrina | $20.58 | 2024 | |
| Merck Sharp & Dohme LLC | $20.29 | 2023 | Gardasil 9 |
| Exact Sciences Corporation | $20.08 | 2025 | The Cologuard Plus Collection Kit |
| Biohaven Pharmaceuticals, INC. | $19.99 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $17.73 | 2022 | |
| Shield Therapeutics INC | $14.79 | 2024 | |
| Channel Medsystems, INC. | $14.19 | 2022 | |
| Mission Pharmacal Company | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Uaje listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.